Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C, Gentile D, Gatzemeier W, Sagona A, Barbieri E, Testori A, Errico V, Bottini A, Marrazzo E, Dani C, Dozin B, Boni L, Bruzzi P, Fernandes B, Franceschini D, Spoto R, Torrisi R, Scorsetti M, Santoro A, Canavese G; SINODAR-ONE Collaborative Group. Tinterri C, et al. Among authors: torrisi r. Ann Surg Oncol. 2022 Sep;29(9):5732-5744. doi: 10.1245/s10434-022-11866-w. Epub 2022 May 12. Ann Surg Oncol. 2022. PMID: 35552930 Clinical Trial.
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.
Colleoni M, Rotmensz N, Maisonneuve P, Sonzogni A, Pruneri G, Casadio C, Luini A, Veronesi P, Intra M, Galimberti V, Torrisi R, Andrighetto S, Ghisini R, Goldhirsch A, Viale G. Colleoni M, et al. Among authors: torrisi r. Ann Oncol. 2007 Oct;18(10):1632-40. doi: 10.1093/annonc/mdm268. Epub 2007 Aug 22. Ann Oncol. 2007. PMID: 17716986 Free article.
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E, Viale G, Rotmensz N, Maisonneuve P, Galimberti V, Luini A, Intra M, Veronesi P, Mazzarol G, Pruneri G, Renne G, Torrisi R, Cardillo A, Cancello G, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: torrisi r. Breast Cancer Res Treat. 2009 Nov;118(2):385-94. doi: 10.1007/s10549-009-0446-6. Epub 2009 Jun 27. Breast Cancer Res Treat. 2009. PMID: 19562480 Free article.
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.
Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Veronesi P, Torrisi R, Montagna E, Luini A, Intra M, Gentilini O, Ghisini R, Goldhirsch A, Colleoni M. Cancello G, et al. Among authors: torrisi r. Ann Oncol. 2010 Oct;21(10):1974-1981. doi: 10.1093/annonc/mdq072. Epub 2010 Mar 23. Ann Oncol. 2010. PMID: 20332136 Free article.
Fulvestrant for advanced male breast cancer patients: a case series.
Masci G, Gandini C, Zuradelli M, Pedrazzoli P, Torrisi R, Lutman FR, Santoro A. Masci G, et al. Among authors: torrisi r. Ann Oncol. 2011 Apr;22(4):985. doi: 10.1093/annonc/mdr005. Ann Oncol. 2011. PMID: 21447621 Free article. No abstract available.
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F, Garcia-Etienne C, Clivio A, Cozzi L, Mancosu P, Nicolini G, Vanetti E, Eboli M, Rossetti C, Rubino A, Sagona A, Arcangeli S, Gatzemeier W, Masci G, Torrisi R, Testori A, Alloisio M, Santoro A, Tinterri C. Scorsetti M, et al. Among authors: torrisi r. Radiat Oncol. 2012 Aug 28;7:145. doi: 10.1186/1748-717X-7-145. Radiat Oncol. 2012. PMID: 22929062 Free PMC article.
151 results